SCHEDULE: Madison Avenue Entities Report Stake in STAAR SURGICAL
Beneficial Ownership Filing
Several Madison Avenue-affiliated entities and Eli Samaha have reported a combined beneficial ownership of 8.4% of STAAR SURGICAL CO's common stock as of June 30, 2026.
Summary
- Madison Avenue International LP, along with related entities Madison Avenue Partners, LP, EMAI Management, LLC, Madison Avenue GP, LLC, Caraway Jackson Investments LLC, and Eli Samaha, collectively hold 4,175,748 shares of STAAR SURGICAL CO's common stock.
- This holding represents approximately 8.4% of the company's outstanding common stock as of June 30, 2026.
- The filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership.
- The reporting persons certify that the securities were not acquired for the purpose of influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports a change in beneficial ownership without disclosing new strategic information or financial performance.
Positives
- The reporting persons have disclosed their holdings, providing transparency to the market.
- The aggregate beneficial ownership of 8.4% indicates a significant, but not controlling, stake.
Negatives
- No new financial performance or strategic updates are provided in this filing.
Risks
- While not explicitly stated as a risk in this filing, significant changes in beneficial ownership can sometimes precede activist investor campaigns or strategic shifts, which could introduce uncertainty.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance.
Management Comments
- By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment funds accumulating significant stakes in public companies. This filing indicates a notable position in the ophthalmic surgical device sector, where STAAR SURGICAL operates.
Stakeholder Impact
- Shareholders: Increased transparency regarding significant ownership stakes.
- Management: Awareness of a substantial beneficial owner, potentially influencing future corporate actions or governance discussions.
Key Dates
| Date | Description |
|---|---|
| 05/08/2026 | Date of STAAR SURGICAL CO's Quarterly Report on Form 10-Q disclosing outstanding shares. |
| 05/13/2026 | Date STAAR SURGICAL CO's Quarterly Report on Form 10-Q was filed. |
| 04/20/2026 | Date of previous Schedule 13G filing by the Reporting Persons. |
| 06/30/2026 | Date as of which beneficial ownership is reported. |
| 08/14/2026 | Date of certification and signature for this Schedule 13G filing. |
Keywords
STAAR SURGICAL, Schedule 13G, beneficial ownership, Madison Avenue, Eli Samaha, investment management, Cayman Islands, Delaware
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.